Profile: Advanced Cell Technology, Inc. provides therapies for a broad range of diseases which includes myoblasts for treating heart failure, hemangioblasts for treating blood disorders, cardiovascular disease &cancer, retinal pigment epithelial cells for treating macular degeneration & other retinal degenerative disorders, skin cells for dermatological conditions, neuronal cells for spinal cord injury and liver cells for hepatitis and cirrhosis. We are focused on using our technology to generate stable cell lines including retinal pigment epithelium (RPE) cells for the treatment of eye disease.